Rajagopal, Vivek <br/><br/>
Outcomes of patients with acute coronary syndromes who are treated with bivalirudin during percutaneous coronary intervention: an analysis from the Randomized Evaluation in PCI Linking Angiomax to Reduced Clinical Events (REPLACE-2) trial.  [electronic resource] 

 -  American heart journal  Jul 2006 
 - 149-54 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article 
<br/><br/><label>ISSN: </label>1097-6744 
<br/><br/><label>Standard No.: </label>10.1016/j.ahj.2005.09.007  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Angina, Unstable--drug therapy<br/>Angioplasty, Balloon, Coronary<br/>Anticoagulants--economics<br/>Antithrombins--economics<br/>Combined Modality Therapy<br/>Drug Therapy, Combination<br/>Female<br/>Heparin--economics<br/>Hirudins--economics<br/>Humans<br/>Male<br/>Middle Aged<br/>Myocardial Infarction--drug therapy<br/>Peptide Fragments--economics<br/>Platelet Glycoprotein GPIIb-IIIa Complex--antagonists & inhibitors<br/>Randomized Controlled Trials as Topic<br/>Recombinant Proteins--economics<br/>Syndrome<br/>Treatment Outcome<br/>United States